Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

December 7, 2022

Caris and Hummingbird Bioscience collaborate to advance anti-HER3 therapy

Molecular science and technology company Caris Life Sciences (Caris) and data-driven precision biotherapeutics company Hummingbird Bioscience has announced a strategic collaboration to advance clinical development of latter’s anti-HER3 therapy, HMBD-001.

Caris and Hummingbird Bioscience collaborate to advance anti-HER3 therapy